Patents Assigned to Solventum Intellectual Properties
-
Fluorescent glazing composition for a dental zirconia article, process of sintering and kit of parts
Patent number: 12121599Abstract: The invention relates to a glazing composition for a porous dental zirconia article, the glazing composition comprising liquid, glass particles, fluorescing component(s) comprising europium, optionally hydrophilic silica nano-particles, and optionally hydrophobic silica nano-particles, wherein the fluorescing component(s) can be contained in the glass particles or as separate component. The invention also relates to a process for sintering a porous dental zirconia article with a glazing composition on its surface.Type: GrantFiled: August 30, 2019Date of Patent: October 22, 2024Assignee: Solventum Intellectual Properties CompanyInventors: Michael Jahns, Jacqueline C. Rolf, Martin Goetzinger, Holger Hauptmann -
Patent number: 12121115Abstract: Aspects of the present disclosure relate to a self-mating fastener that includes a backing having a first side, and a rail element protruding perpendicularly from the first side of the backing. The rail element extends in a longitudinal direction along the backing. The rail element has a base portion attached to the first side of the backing and a cap portion distal from the backing. The cap portion has a cap width that is greater than a width of the base portion and the cap portion overhangs the base portion on opposing sides. The self-mating fastener includes an electrically conductive contact element proximate to the rail element.Type: GrantFiled: April 7, 2020Date of Patent: October 22, 2024Assignee: Solventum Intellectual Properties CompanyInventors: Cory M. Arthur, David T. Buckley, Dylan T. Cosgrove, Kurt J. Halverson, Karl M. Kropp, Audrey A. Sherman, Steven P. Swanson
-
Patent number: 12123048Abstract: A self-contained biological sterilization indicator comprises: a housing; bacterial spores comprising, and/or capable of producing, an enzyme capable of catalyzing cleavage of an enzyme substrate; and a frangible container containing a composition, wherein the composition comprises the enzyme substrate, wherein if the frangible container is broken the composition will contact the bacterial spores to form a mixture having an initial pH in the range from 6.0 to 9.0. The enzyme substrate comprises a fluorinated 4?-alkylumbelliferyl ?-D-glucopyranoside represented by the structural formula (I) wherein one of R1 and R2 is F and the other is H, and R3 is an alkyl group having from 1 to 12 carbon atoms. A biological sterilization indicator comprising a kit containing isolated components comprising (i) bacterial spores comprising, and/or capable of producing, an enzyme capable of catalyzing cleavage of the enzyme substrate and a method of assessing efficacy of a sterilization process are also disclosed.Type: GrantFiled: December 3, 2019Date of Patent: October 22, 2024Assignee: Solventum Intellectual Property CompanyInventors: Tonya D. Bonilla, Stephen B. Roscoe, George W. Griesgraber
-
Patent number: 12115331Abstract: This disclosure includes wound dressings and systems for effluent management of topical wound therapy and related methods. Some devices, which are configured to dilute therapeutic gas effluent flowing from a dressing, comprise a therapeutic gas source configured to provide therapeutic gas to the dressing; a container comprising a sidewall that defines a chamber configured to receive therapeutic gas effluent from the dressing; a negative pressure source configured to be coupled to the container such that the negative pressure source can be activated to draw fluid from the dressing through the chamber of the container; and a diluent gas source configured to deliver a diluent gas to dilute therapeutic gas effluent before the therapeutic gas effluent enters the negative pressure source.Type: GrantFiled: September 10, 2021Date of Patent: October 15, 2024Assignee: Solventum Intellectual Properties CompanyInventors: Justin Alexander Long, Christopher Brian Locke, Timothy Mark Robinson, Richard Coulthard
-
Patent number: 12109354Abstract: Systems, apparatuses, and methods for instilling fluid to a tissue site in a negative-pressure therapy environment are described. Illustrative embodiments may include a pneumatically-actuated instillation pump that can draw a solution from a solution source during a negative-pressure interval, and instill the solution to a dressing during a venting interval. A pneumatic actuator may be mechanically coupled to a disposable distribution system that can provide a fluid path between the solution source and a distribution component. A bacterial filter may be disposed in the fluid path between the actuator and the distribution component to prevent contamination of the actuator during operation. The distribution system may be separated from the actuator and disposed of after operation, and the actuator may be re-used.Type: GrantFiled: April 1, 2021Date of Patent: October 8, 2024Assignee: Solventum Intellectual Properties CompanyInventors: Benjamin Andrew Pratt, Christopher Brian Locke
-
Semi-automated system for real-time wound image segmentation and photogrammetry on a mobile platform
Patent number: 12112477Abstract: In one example embodiment, a wound imaging system includes a user interface, a computer processor, and an active contouring module. The user interface is configured to display an image of a wound acquired by the wound imaging system and selectively receive inputs from a user defining an initial perimeter of the wound. An active contouring module is configured to operate on the computer processor to receive the inputs defining the initial perimeter of the wound, identify features of the image on opposing sides of the initial perimeter of the wound, and identify an actual perimeter of the wound based on the initial perimeter of the wound and the identified features. The user interface is further configured to display, on the image of the wound, the actual perimeter of the wound as identified by the active contouring module and selectively receive inputs from the user to modify the actual perimeter of the wound.Type: GrantFiled: September 1, 2023Date of Patent: October 8, 2024Assignee: Solventum Intellectual Properties CompanyInventor: Brett L. Moore -
Patent number: 12102499Abstract: A method of applying a two-part dental sealant is described comprising providing a syringe device (1) comprising a cartridge (10) including first and second chamber. The first chamber contains a first part of a dental sealant comprising a (meth)acrylate resin and an oxidizing curing agent. The second chamber contains a second part of a dental sealant comprising a (meth)acrylate resin and a reducing curing agent that reacts with the oxidizing curing agent of the first chamber. The first and/or second part of the dental sealant further comprise a single component or multiple components that neutralize acid and promote remineralization. The syringe device comprises a dispensing nozzle (17) comprising a static mixer and an outlet at one end of the cartridge and a plunger (20) at the opposing end of the cartridge. Also described is a kit for storing and applying the dental sealant is described.Type: GrantFiled: June 4, 2019Date of Patent: October 1, 2024Assignee: Solventum Intellectual Properties CompanyInventors: Randilynn B. Christensen, Kenton D. Budd, Afshin Falsafi, Mahmut Aksit, Jana Ninkovic, Jie J. Liu, Mark B. Agre, Masayuki Nakamura, Jason W. Bjork, Bradley D. Craig, Richard P. Rusin, Paul J. Homnick, Joel D. Oxman, Yizhong Wang, Paul R. Klaiber, Bill H. Dodge
-
Patent number: 12102509Abstract: In some non-limiting examples, a system for stimulating tissue growth at a tissue site may include a porous foam and a moisture barrier. The porous foam may include an exterior-facing surface, a tissue contact surface, and a plurality of struts positioned at the tissue contact surface. The plurality of struts may be configured to contact the tissue site and to create tissue deformation at the tissue site without the application of a reduced pressure. The moisture barrier may be configured to cover the exterior-facing surface of the porous foam and to trap moisture at the tissue site. Also provided are other systems, apparatus, and methods suitable for stimulating tissue growth.Type: GrantFiled: May 24, 2018Date of Patent: October 1, 2024Assignee: Solventum Intellectual Properties CompanyInventors: T. Blane Sanders, Christopher Allen Carroll, Hannah I. Grothues
-
Patent number: 12102511Abstract: A manifold for treating a tissue site may include a first side and a second side opposite the first side. The second side of the manifold may be configured to face the tissue site, and to contract a greater amount than the first side of the manifold when exposed to a compressive force. In some illustrative examples, the manifold may be configured to distribute reduced pressure to the tissue site, and to contract when exposed to the reduced pressure. The manifold may be suitable for use with dressing assemblies, treatment systems, and methods for treating a tissue site.Type: GrantFiled: October 13, 2021Date of Patent: October 1, 2024Assignee: Solventum Intellectual Properties CompanyInventor: Deepak V. Kilpadi
-
Patent number: 12104000Abstract: The present disclosure provides a photopolymerizable composition. The photopolymerizable composition includes at least one polypropylene oxide component and an initiator, plus optionally a urethane component, a multifunctional reactive diluent, and/or an inhibitor. The present disclosure also provides an article including the reaction product of the photopolymerizable composition. Typically, the article exhibits an elongation at break of 30% or greater. Further, the present disclosure provides a method of making an article. The method includes (i) providing a photopolymerizable composition and (ii) selectively curing the photopolymerizable composition to form an article. The method optionally also includes (iii) curing unpolymerized polypropylene oxide component, urethane component and/or multifunctional reactive diluent remaining after step (ii).Type: GrantFiled: March 6, 2019Date of Patent: October 1, 2024Assignee: Solventum Intellectual Properties CompanyInventors: Ahmed S. Abuelyaman, Zeba Parkar, John M. Riedesel
-
Patent number: 12102748Abstract: A dressing includes a manifold layer and a drape coupled to the manifold layer and configured to seal the manifold layer over a wound. The drape has an opening extending therethrough. A connection pad is positioned at the opening and configured to couple the dressing to a tube. The connection pad includes an outer ring coupled to the drape and a center dimple extending away from the drape and defining a volume between the center dimple and a plane defined by the outer ring. The dressing also includes an absorbent manifolding structure positioned between the center dimple and the manifold layer and formed to substantially match a shape of the volume.Type: GrantFiled: August 11, 2020Date of Patent: October 1, 2024Assignee: Solventum Intellectual Properties CompanyInventors: Christopher Brian Locke, Timothy Mark Robinson
-
Patent number: 12097094Abstract: A reduced pressure dressing for applying reduced pressure treatment to a tissue site includes an interface layer adapted to be positioned at the tissue site. An absorbent layer is in fluid communication with the interface layer to absorb liquid from at least one of the interface layer and the tissue site. A pump is in fluid communication with the absorbent layer to deliver a reduced pressure to the tissue site. A cover is positioned over the pump, the absorbent layer, and the interface layer to maintain the reduced pressure at the tissue site, and a liquid-air separator is positioned between the absorbent layer and the pump to inhibit liquid from entering the pump.Type: GrantFiled: April 28, 2021Date of Patent: September 24, 2024Assignee: Solventum Intellectual Properties CompanyInventors: Jonathan Paul Jaeb, Richard Daniel John Coulthard, Timothy Mark Robinson, Christopher Brian Locke, Aidan Marcus Tout
-
Patent number: 12097093Abstract: A dressing for treating a tissue site with negative pressure may include a first layer configured to deform under a first predetermined negative pressure, and a second layer. The second layer may include an indicator configured to remain visible or hidden until the first layer deforms.Type: GrantFiled: April 9, 2019Date of Patent: September 24, 2024Assignee: Solventum Intellectual Properties CompanyInventor: Christopher Brian Locke
-
Patent number: 12099046Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for optimizing a process of manufacturing a biologic pharmaceutical. In one aspect, the method comprises repeatedly performing the following: i) selecting a configuration of input settings for manufacturing a batch of a biologic pharmaceutical based on a causal model that measures current causal relationships between input settings and a measure of a quality of batches of the biological pharmaceutical; ii) determining a measure of the quality of a batch of the biological pharmaceutical manufactured using the configuration of input settings; and iii) adjusting, based on the measure of the quality of the batch of the biological pharmaceutical, the causal model.Type: GrantFiled: October 3, 2019Date of Patent: September 24, 2024Assignee: Solventum Intellectual Properties CompanyInventors: Brian E. Brooks, Gilles J. Benoit, Peter O. Olson, Tyler W. Olson, Himanshu Nayar, Frederick J. Arsenault, Nicholas A. Johnson, Susan L Woulfe, Mark A. Tomai
-
Patent number: 12091844Abstract: The present invention relates to a filtration system (1) having the faucet (20). The faucet (20) comprises: a mixing valve, wherein the mixing valve is provided with a first inlet passage, a second inlet passage, and a mixing valve outlet passage, wherein the first inlet passage is connected to a first fluid line (L2), and the second inlet passage is connected to a second fluid line (L3); an outflowing pipe (23), wherein one end of the outflowing pipe (23) is connected to the mixing valve outlet passage; and a mode selection device (25), wherein the mode selection device (25) being operable to selectively allow one or both of the first fluid line (L2) and the second fluid line (L3) to communicate with the mixing valve outlet passage. The faucet (20) further comprises a mixing ratio adjustment device, the mixing ratio adjustment device and the mode selection device (25) operating independently from each other.Type: GrantFiled: November 2, 2020Date of Patent: September 17, 2024Assignee: Solventum Intellectual Properties CompanyInventors: Biyong Qiu, JianYi Song
-
Patent number: 12086741Abstract: Crowd funding for innovation includes distributing a proposal with a description of a project idea, an amount of funds requested, and a time frame for raising the funds. Ownership of the project is transferred to an entity, which receives contributions from contributors and for each of the received contributions converts the contribution to a corresponding amount of virtual coin and adds the contribution to the funds. If the funding goal is complete within the time frame, the entity converts the coins to actual money and releases the money to the requestor. After completion of the project, the entity determines if the project is successful and can commercialize successful projects. For certain successful projects, the entity can also distribute funds to the contributors.Type: GrantFiled: December 14, 2020Date of Patent: September 10, 2024Assignee: Solventum Intellectual Properties CompanyInventors: Audrey A. Sherman, Robert R. Kieschke, Frank J. Sherman, Mario A. Perez, Raymond P. Johnston, Kandyce M. Bohannon
-
Patent number: 12076210Abstract: An orthodontic bracket can include a bracket body. The bracket body can include an outer body. The bracket body can also include an inner body coupled to the outer body. The orthodontic bracket can include a bracket base configured to couple to a tooth. The inner body of the outer body is disposed between the outer body and the bracket base.Type: GrantFiled: December 8, 2022Date of Patent: September 3, 2024Assignee: Solventum Intellectual Properties CompanyInventor: Richard E. Raby
-
Patent number: 12076217Abstract: Provided herein is a system and method for trauma-free application and removal of light deactivated adhesive drapes. One aspect provides a system comprising a drape, at least one photosensitive adhesive portion having a release agent, and at least one acrylic and/or polyurethane adhesive portion, where the system is adapted to be coupled to a tissue site and released therefrom upon or after exposure to an external stimulus such as certain wavelengths of light. The system may have a removable blocking layer to prevent the photosensitive adhesive from being exposed to deactivation wavelengths prematurely. Another aspect provides a method for application and removal of a drape using by removing the removable blocking layer and applying light to the drape to deactivate the photosensitive adhesive portion and promote easy, clean, and less painful removal of the drape.Type: GrantFiled: February 18, 2019Date of Patent: September 3, 2024Assignee: Solventum Intellectual Properties CompanyInventors: Christopher Brian Locke, David Whyte
-
Patent number: 12076218Abstract: Systems and methods for delivering a foamed fluid to a wound of a patient (e.g., through a wound dressing covering the wound and coupled to the skin around the wound).Type: GrantFiled: January 13, 2021Date of Patent: September 3, 2024Assignee: Solventum Intellectual Properties CompanyInventors: Timothy Mark Robinson, Joanna Perkins
-
Patent number: 12075322Abstract: The present disclosure relates to a network system. The system is formed by at least two negative pressure wound therapy (NPWT) devices. The first NPWT device includes a wireless radio, user interface, controller, and processing circuit. The wireless radio wirelessly communicates with the second NPWT device. The user interface displays operational status of therapy operation, receives a command of operational change from a user, and displays wireless radio connection strength between the first NPWT device and the NPWT device. The controller controls therapy operation of the first NPWT device based on input from the user interface. The processing circuit causes the wireless radio to communicate with the second NPWT device, determines wireless radio connection strength between the first NPWT device and the second NPWT device based on communication between the first NPWT device and the second NPWT device, and causes the user interface to display determined wireless radio connection strength.Type: GrantFiled: October 29, 2019Date of Patent: August 27, 2024Assignee: Solventum Intellectual Properties CompanyInventors: Brett L. Moore, Justin Rice, Edward Lee, Christian Romero, Shannon C. Ingram